Table 1

Clinical characteristics from the ductal carcinoma samples.

Sample Name

Stage

Age

TNM

LN

Grade

Molecular Markers


9T

IIa

55 years

T2N0M0

Negative

Grade I SBR

ER +/ PR +/ p53 -/ ERBB2+ (3+)

20T

IIb

87 years

T2N0M0

Negative

Grade II SBR

ER +/ PR -/ p53 -/ ERBB2+ (3+)

22T

IIb

56 years

T2N1M0

Positive

Grade III SBR

ER +/ PR -/ p53 -/ ERBB2+ (2+/3+)

28T

IIIa

42 years

T2N2M0

Positive

Grade II SBR

ER +/ PR -/ p53 -/ ERBB2+ (3+)

36T

I

45 years

T1N0M0

Negative

Grade III SBR

ER +/ PR -/ p53 -/ ERBB2+ (3+)


Age: age of diagnosis; TNM: classification according to TNM (T – size; N – lymph node status; M – presence of metastasis); LN: involvement of sentinel lymph nodes; grade: grades I, II and III according to SBR; molecular markers: ER – estrogen receptor; PR – progesterone receptor; p53 – protein TP53; and ERBB2 – protein ERBB2.

Ferreira et al. BMC Genomics 2010 11(Suppl 5):S4   doi:10.1186/1471-2164-11-S5-S4

Open Data